Oncology & Cancer
Study finds increase in number of non-smokers being diagnosed with lung cancer
There has been an increase in the number of non-smokers being diagnosed with non-small cell lung cancer, according to new findings.
Sep 4, 2012
0
0
Non Small Cell Lung Cancer
Oncology & Cancer
Painless skin rash predicts survival benefit from latest lung cancer drug, study finds
(Medical Xpress)—Elderly patients with advanced non small cell lung cancer (NSCLC) who developed a rash within 28 days of receiving the targeted drug erlotinib (Tarceva) survived on average 6.2 months, compared to 4.1 ...
Oct 17, 2012
0
0
Oncology & Cancer
Drug resistance biomarker could improve cancer treatment
Cancer therapies often have short-lived benefits due to the emergence of genetic mutations that cause drug resistance. A key gene that determines resistance to a range of cancer drugs has been reported in a study published ...
Nov 21, 2012
0
0
Oncology & Cancer
Researchers identify gene involved in lung tumor growth
Lung cancer researchers at St. Joseph's Hospital and Medical Center in Phoenix, Ariz., in collaboration with researchers at the Translational Genomics Research Institute and other institutions, have identified a gene that ...
Nov 29, 2012
0
0
Oncology & Cancer
Кesearchers identify gene variations that may help predict cancer treatment response
Researchers at the Moffitt Cancer Center have identified four inherited genetic variants in non-small cell lung cancer patients that can help predict survival and treatment response. Their findings could help lead to more ...
Aug 9, 2013
0
0
Oncology & Cancer
New drug extends advanced lung cancer survival
A new drug can help advanced lung cancer patients live longer and may aid in treating other kinds of cancer, researchers said Monday.
Jun 3, 2013
0
0
Oncology & Cancer
Palliative radiation use for lung cancer higher than advised
(HealthDay)—Half of patients with metastatic non-small-cell lung cancer (NSCLC) receive at least one course of palliative radiation therapy (RT), with younger patients and those who received chemotherapy or surgery more ...
Jan 18, 2013
0
0
Medications
FDA approves genetic test for lung cancer drug
The Food and Drug Administration says it approved a genetic test from Roche to help doctors identify patients who can benefit from a lung cancer drug made by Genentech.
May 14, 2013
0
1
Oncology & Cancer
Adding bavituximab to second-line chemotherapy doubles response rate
Adding the monoclonal antibody bavituximab to docetaxel chemotherapy doubles overall response rate and improves progression-free survival and overall survival in late-stage non-squamous, non-small cell lung cancer (NS-NSCLC) ...
Sep 6, 2012
0
0
Oncology & Cancer
Program linked to medical oncology practice improvement
(HealthDay)—For medical oncology practices in the United States, participation in the American Society of Clinical Oncology's Quality Oncology Practice Initiative (QOPI) correlates with improvements in measured performance, ...
Apr 6, 2013
0
0
